JPRN-UMIN000015998招募中2 期
Phase II study of gemcitabine, carboplatin and dexamethasone with or without rituximab for patients with relapsed or refractory non-Hodgkin's lymphoma - GHG-GCD
Gifu University Hospital0 个研究点目标入组 20 人开始时间: 2014年12月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients have CNS invasion. 2) HIV antibody positive. 3) Patients have interstitial pneumonia or pulmonary fibrosis evidenced by chest X-ray and/or chest CT. 4) Patients undergoing chest radiotherapy. 5) Patients have major heart/lung disorders, or uncontrolled diabetes mellitus. 6) Patients are pregnant or lactating women. Patients cannot or will not use birth control during the treatment. 7) Patients have active other malignant diseases. 8) Patients have severe allergic symptoms. 9) Patients have chemotherapy resistant lymphoma. 10) Inadequate for clinical trial entry by the attending physicians.
研究者
相似试验
进行中（未招募）
2 期
GHG-GCDrelapsed or refractory non-Hodgkin's lymphomaJPRN-jRCT1041230085Tsurumi Hisashi20
进行中（未招募）
1 期
ew treatment option for refractory testicular cancer.Refractory histologically confirmed extracranial primary germ cell cancer, seminoma, or nonseminoma germ cell tumoursEUCTR2016-000171-24-SKárodný onkologický ústav43
招募中
2 期
A Phase II study of Gemcitabine, Cisplatin and Bevacizumab for the patients with first recurrent and refractory ovarian clear cell carcinomaJPRN-UMIN000051087Kansai Clinical Oncology Group(KCOG)28
尚未招募
不适用
Phase I study of gemcitabine and carboplatin plus sorafenib in patients with advanced solid tumorsadvanced solid tumors10027655CancerNL-OMON31053Antoni van Leeuwenhoek Ziekenhuis28
招募中
2 期
Biliary tract cancer cross-over studybiliary tract cancerJPRN-jRCT1041230014Yamashita Tatsuya50